Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes
about
A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different MethodsA network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP)Viral and Host Characteristics of Recent and Established HIV-1 Infections in Kisumu based on a Multiassay Approach.Performance characteristics of an antibody-based multiplex kit for determining recent HIV-1 infection.Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based SurveyPerformance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 IncidenceAnalysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in BotswanaExtensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries.Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay.Moving towards a reliable HIV incidence test - current status, resources available, future directions and challenges ahead.Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.Short Communication: Heightened HIV Antibody Responses in Postpartum Women as Exemplified by Recent Infection Assays: Implications for Incidence Estimates.Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.Short Communication: The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection.High HIV-1 RNA among Newly Diagnosed People in Botswana.Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine.HIV-1 envelope sequence-based diversity measures for identifying recent infections.Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.Cross-Sectional HIV Incidence Surveillance: A Benchmarking of Approaches for Estimating the 'Mean Duration of Recent Infection'.Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece
P2860
Q28546966-DB6F35B0-D3F8-45CD-915B-7B58E8367B2FQ29248885-EF7C6B74-5E84-4A28-B241-7DF1D0C43552Q30830042-D6FB2E50-1E01-4932-82BF-785FB037E0A1Q33637675-19FE2D9C-A2A1-4755-817B-8929FFC2D547Q36022269-FE665D52-CE5E-45BF-A19B-F1E942F29A17Q36029177-6EA4D197-3C2A-4108-A1DC-1A6DD1824DFEQ36101267-1FC81F29-A747-43F6-A925-076693958738Q36110367-1F2E009B-A59F-4491-A64D-2955FB8BD64CQ36117011-4D79F645-8CA4-42BA-9D40-5E19E2024F94Q36330026-9D8CBD0C-0AF5-4BB5-8D33-53DDEC8E9763Q37643256-3AEA2CD3-6FF1-4316-A5B4-282B79C57875Q38649701-EBBC693A-EC3A-4AE5-AC34-97A604F8C892Q38779402-8F41BDFA-AAD4-4BFC-BB8F-11B5CC0820A4Q38963716-CDD3F16F-2880-40B6-8B37-E8E0F163DBFDQ40237431-DCF2BB78-998D-4915-8F6F-78833647D07EQ40285384-D7F6CD68-4698-4ED8-92E7-DED8F64E332BQ40440245-F24E724D-A611-4020-9B25-2D4F92708452Q45305937-33A89759-6493-4C4C-93E7-F657045A8A15Q45323727-A37B622E-FA46-495D-86E1-44B3D89216D8Q47556200-132B6D64-B5B3-44BC-8615-114F7F394FA1Q48336460-F5E52DD6-68C3-4A08-B7E0-58C6CAED84F8Q50089242-A2B81BFE-9979-4CEB-887D-A4FF1CE56A50Q52681670-EDB9D409-F570-4735-AF67-662B404BE2B3Q53274310-7CEC7631-AD5F-4FA3-B3BC-2F71598699EBQ57092218-7591DF6E-1BF8-4759-AB80-4D2894DEA1A2
P2860
Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@ast
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@en
type
label
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@ast
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@en
prefLabel
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@ast
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@en
P2093
P2860
P1433
P1476
Recalibration of the limiting ...... on in divergent HIV-1 subtypes
@en
P2093
Alex Welte
Andrea A Kim
Anindya De
Bharat S Parekh
Boonyos Raengsakulrach
Chonticha Kittinunvorakoon
Erin Rottinghaus
Haiying Yu
John Nkengasong
Kachit Choopanya
P2860
P304
P356
10.1371/JOURNAL.PONE.0114947
P407
P577
2015-02-24T00:00:00Z